Invenomic Capital Management’s Sabre SABR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-170,123
Closed -$1.53M 176
2022
Q1
$1.53M Sell
170,123
-3,048
-2% -$29.9K 0.16% 114
2021
Q4
$1.49M Buy
173,171
+110,610
+177% +$1.06M 0.32% 89
2021
Q3
$741K Buy
+62,561
New +$709K 0.24% 96

Other funds holding SABR

Invenomic Capital Management's SABR Position: Q2 2022 in Review

Invenomic Capital Management sold out of Sabre (SABR) in Q2 2022, closing a stake of 170,123 shares — an estimated $1.53M sold.

Invenomic Capital Management first reported a position in SABR in Q3 2021 and held it in 3 quarters. The position peaked at $1.53M in Q1 2022. 326 funds tracked by Wall St. Rank hold SABR as of Q2 2022.

  • Invenomic Capital Management reported no remaining Sabre position as of Q2 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 170,123 Sabre shares in Q2 2022, an estimated $1.53M.
  • Invenomic Capital Management first reported a position in Sabre in Q3 2021 and held it in 3 quarters.
  • Invenomic Capital Management's Sabre position peaked at $1.53M in Q1 2022.
  • 326 funds tracked by Wall St. Rank held Sabre as of Q2 2022.

Based on Invenomic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.